Last reviewed · How we verify
NCT06279312
The Effect of Adaptogen Elixir on Sleep Improvement
NA trial testing Placebo drink in Sleep Disorder in 52 participants. Completed in 1 April 2025.
31 July 2024
Quick facts
| Lead sponsor | TCI Co., Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 52 |
| Start date | 26 February 2024 |
| Primary completion | 31 July 2024 |
| Estimated completion | 1 April 2025 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Placebo drink — full drug profile →
- Adaptogen Elixir drink
Conditions studied
- Sleep Disorder — all drugs for Sleep Disorder →
- Anxiety Disorders — all drugs for Anxiety Disorders →
Sponsor
TCI Co., Ltd. — full company profile →
Who can join
Adults 18 to 65, any sex, with Sleep Disorder or Anxiety Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to examine the effectiveness of Adaptogen Elixir herbal drink in relieving emotions and improving sleep quality. Participants will be randomly assigned to either the placebo group or the Adaptogen Elixir herbal drink group, with 25 participants in each group. On the day of the experiment (week 0), participants are required to collect blood and saliva samples, fill out questionnaires assessing sleep disorders and stress condition, and use a sleep monitoring system to track their sleep and autonomic nervous system conditions. Subsequently, participants will be given the experimental samples and instructed to consume them continuously for 4 weeks following the instruction. Follow-up assessments will be conducted in the 2nd and 4th weeks, participants are required to collect blood and saliva samples, fill out questionnaires assessing sleep disorders and stress condition, and use a sleep monitoring system to track their sleep and autonomic nervous system conditions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06279312
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sleep Disorder
Currently open trials in the same condition.
- NCT07485790 — The Effects of Yoga on Pregnant Women · NA · recruiting
- NCT06990256 — Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers · NA · recruiting
- NCT04949360 — SleepUp Digital CBTi-based Platform for Insomnia · NA · recruiting
- NCT05649514 — Sleep Impairment in Subjects at Risk of Developing Alzheimer's Disease · NA · recruiting
- NCT06914466 — Neural Mechanisms and Clinical Applications of DBS for Modulating Sleep Dysregulation in PD · recruiting
Other TCI Co., Ltd. trials
Trials by the same sponsor.
- NCT07379216 — Efficacy Evaluation Study of Vitamin C and Glutathione Liquid Sachet · NA · recruiting
- NCT07302828 — Effect of Double Nutri® Liposomal Encapsulation Technology on Human Absorption of Vitamin C and Glutathione Liquid Sache · NA · completed
- NCT07172607 — The Effect of Avnace eZZe on Sleep Improvement · NA · recruiting
- NCT07097987 — Evaluation of the Efficacy of the Composite WM Formula in Promoting GLP-1 Secretion · NA · not yet recruiting
- NCT07097974 — Evaluation of the Efficacy of the Composite WM Formula in Body Weight Change · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06279312 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by TCI Co., Ltd.
- Last refreshed: 11 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06279312.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing